WHO ICTRP trial
DNA repair gene expression levels in NSCLC patients treated with platinum based…
EUCTR2008-000936-42-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2008-000936-42-IT |
|---|---|
| Public title | DNA repair gene expression levels in NSCLC patients treated with platinum based chemotherapy: an open label randomized phase II study - ND |
| Scientific title | DNA repair gene expression levels in NSCLC patients treated with platinum based chemotherapy: an open label randomized phase II study - ND |
| Primary sponsor | AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | PATIENTS WITH NSCLC CANCER MedDRA version: 9.1 Level: LLT Classification code 10059515 Term: Non-small cell lung cancer metastatic |
| Interventions | Trade Name: TAXOTERE*INFUS FL 80MG/2ML+F Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: Docetaxel Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 80- Trade Name… |
| Registration date | May 21, 2008 |
| Secondary IDs | GENE-REPAIR |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: